CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 64 enrolled
Drug / intervention
Prochlorperazine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00590317
NCT00590317Phase 2Completed
CompareCT.gov

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

Emory University·interventional·Posted Jan 10, 2008·Updated May 19, 2014

In Brief

A Phase 2 clinical trial evaluating Prochlorperazine and Ondansetron for Nausea and Vomiting. Completed, enrolled 64 participants across 2 sites.

Detailed Summary

This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNausea and Vomiting
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 10, 2008
Enrollment StartMar 1, 2005
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 18.5 years ago

Interventions

Prochlorperazinedrug

Patients receiving Prochlorperazine

Ondansetrondrug

Patients receiving Ondansetron